Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Rob Jones

- PMLiVE

New study highlights significance of chronic obstructive pulmonary disease flare-ups

COPD causes nearly 30,000 deaths in England each year, with an annual overall cost to the NHS of £1.9bn

- PMLiVE

Pfizer and Valneva announce positive phase 2 paediatric data for lyme disease vaccine

VLA15 is currently the only Lyme disease vaccine candidate in clinical development

the contradiction conundrum report cover

The Contradiction Conundrum: New digital pharma report

New research, based on the views of 450 pharma professionals, reveals contradictions in how pharma organisations are approaching their digital products and strategies.

Graphite Digital

- PMLiVE

Innovative Trials named a finalist in the Inspiring Hertfordshire Awards

The patient recruitment organisation has been shortlisted in the Inspiring Hertfordshire awards

Innovative Trials

- PMLiVE

FDA approves COVID-19 treatment for those under the age of 12

Veklury is currently the only COVID-19 treatment approved for this age group

- PMLiVE

Cancer Research UK drives innovation with Cancer Research Horizons

Industry partners will gain access to an extensive network of 4,000 world-leading cancer researchers

- PMLiVE

Gilead’s Veklury significant decreases risk of hospitalisation for COVID-19 patients

Using Veklury within five days of symptom onset – or between five to seven days of symptom onset – reduced hospitalisations in patients at high risk for severe COVID-19 disease

- PMLiVE

Biogen retracts EMA application for Alzheimer’s drug Aduhelm

The application was pulled after the CHMP said the data provided was not enough to support a marketing authorisation

- PMLiVE

Novartis UK launches local charity partnerships to support social mobility pledges

The company has partnered with the Social Mobility Foundation, Founders4Schools and OnSide

- PMLiVE

Lessons from a pandemic – holistic strategy in the time of coronavirus

COVID-19 has delivered a scenario where developing the strategy for any brand is a challenge

- PMLiVE

Is there such a thing as the new normal? Or is it simply the ‘here and now’?

By Chris Grimes-Crompton

The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence

By Michael Phillips

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links